Skip to product information
1 of 1

APRI

Australian Peptide Research Institute

LYZOPHILISED POWDERED FORM. 99% PURITY

TB500

TB500

Regular price $59.99 AUD
Regular price $99.99 AUD Sale price $59.99 AUD
Sale Sold out
Quantity

⚠️ For Research Purposes Only. This product is intended for use in laboratory settings only. Not for human, animal, or pet use. Must be handled in sterile environments. Store between 2–8°C.

TB-500 – Research Applications Overview

TB-500 is a synthetic peptide associated with the actin-binding region of thymosin beta-4 (Tβ4), a naturally occurring peptide involved in cellular movement, tissue remodelling, and repair-related signalling. In experimental settings, TB-500 and related thymosin beta-4 sequences are investigated for their potential roles in cell migration, angiogenesis, inflammatory signalling, and tissue-response pathways.

Key Research Applications

● Tissue Repair & Regeneration Models

Studied in experimental systems examining cellular responses following tissue damage

Used to investigate mechanisms involved in wound closure, tissue remodelling, and repair signalling

Explored for its relationship with biological pathways associated with cellular protection and regeneration

● Cell Migration & Actin Regulation

Used as a research model for examining interactions between thymosin-derived peptide sequences and actin-related pathways

Investigated to understand how actin regulation influences cell movement and structural organisation

Applied in studies examining cytoskeletal dynamics, cellular migration, and tissue remodelling processes

● Angiogenesis & Vascular Research

Studied in models analysing the formation and regulation of new blood vessels

Used to investigate signalling pathways involved in vascular development and tissue recovery

Explored for its potential influence on endothelial-cell migration and angiogenic responses

● Inflammatory & Cellular Stress Pathways

Investigated in experimental models assessing inflammatory signalling and cellular stress responses

Used to explore interactions between repair processes, oxidative stress, and inflammatory mediators

Studied for its potential role in maintaining cellular function following experimental injury

How TB-500 is Studied in Research Settings

● In Vitro (Cell-Based Studies)

Conducted using relevant cell lines and biochemical systems to analyse:

Actin-related interactions

Cell migration and cytoskeletal organisation

Intracellular signalling pathways

Inflammatory and stress-response markers

● In Vivo Preclinical Models

Related thymosin beta-4 peptides are used in controlled animal studies to observe:

Wound-healing and tissue-remodelling responses

Changes in vascular development and blood-vessel formation

Inflammatory and cellular-protection pathways

System-wide physiological adaptations following experimental injury

● Analytical & Pharmacokinetic Research

Studied using laboratory techniques designed to examine:

Peptide identification and structural characteristics

Metabolic breakdown products

Biological stability and clearance

Detection within biological samples

● Molecular & Biochemical Analysis

Techniques include:

Gene-expression analysis related to tissue repair

Protein and signalling-pathway mapping

Inflammatory biomarker measurement

Microscopic analysis of cell migration and tissue organisation

Research Considerations

TB-500 remains an investigational research compound, and its direct biological effects have not been characterised as extensively as those of full-length thymosin beta-4.

Much of the proposed research rationale for TB-500 is derived from studies involving thymosin beta-4 or related peptide fragments rather than direct controlled studies of TB-500 itself.

Research outcomes are typically evaluated through objective cellular, biochemical, vascular, and tissue-remodelling markers under controlled experimental conditions.

Further research is required to establish TB-500’s specific mechanisms, pharmacological properties, safety profile, and potential applications.

View full details

Ultra Fast Delivery Network

Orders placed before 2pm are dispatched the same business day, allowing for minimal delays in processing. APRI works with trusted and efficient delivery partners to ensure fast turnaround times, so your research can begin without unnecessary waiting.

99% purity

All products verified with certificate of analysis

Australian Operated & Owned.

Trusted by researchers across Australia and internationally, APRI operates through a well established global network of pharmaceutical partners in regions including the United States and Europe. This network allows us to source high purity research compounds with a strong focus on quality, consistency, and reliability. Every product is selected to support accurate and reproducible research outcomes, giving researchers confidence in the integrity of their work from start to finish.Option 2